25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          p52 is a subunit of nuclear factor (NF)-κB transcription factors, most closely related to p50. Previously, we have shown that p52, but not p50 homodimers can form transactivating complexes when associated with Bcl-3, an unusual member of the IκB family. To determine nonredundant physiologic roles of p52, we generated mice deficient in p52. Null mutant mice were impaired in their ability to generate antibodies to T-dependent antigens, consistent with an absence of B cell follicles and follicular dendritic cell networks in secondary lymphoid organs, and an inability to form germinal centers. Furthermore, the splenic marginal zone was disrupted. These phenotypes are largely overlapping with those observed in Bcl-3 knockout animals, but distinct from those of p50 knockouts, supporting the notion of a physiologically relevant complex of p52 homodimers and Bcl-3. Adoptive transfer experiments further suggest that such a complex may be critical in accessory cell functions during antigen-specific immune reactions. Possible roles of p52 and Bcl-3 are discussed that may underlie the oncogenic potential of these proteins, as evidenced by recurrent chromosomal translocations of their genes in lymphoid tumors.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          Function and activation of NF-kappa B in the immune system.

          NF-kappa B is a ubiquitous transcription factor. Nevertheless, its properties seem to be most extensively exploited in cells of the immune system. Among these properties are NF-kappa B's rapid posttranslational activation in response to many pathogenic signals, its direct participation in cytoplasmic/nuclear signaling, and its potency to activate transcription of a great variety of genes encoding immunologically relevant proteins. In vertebrates, five distinct DNA binding subunits are currently known which might extensively heterodimerize, thereby forming complexes with distinct transcriptional activity, DNA sequence specificity, and cell type- and cell stage-specific distribution. The activity of DNA binding NF-kappa B dimers is tightly controlled by accessory proteins called I kappa B subunits of which there are also five different species currently known in vertebrates. I kappa B proteins inhibit DNA binding and prevent nuclear uptake of NF-kappa B complexes. An exception is the Bcl-3 protein which in addition can function as a transcription activating subunit in th nucleus. Other I kappa B proteins are rather involved in terminating NF-kappa B's activity in the nucleus. The intracellular events that lead to the inactivation of I kappa B, i.e. the activation of NF-kappa B, are complex. They involve phosphorylation and proteolytic reactions and seem to be controlled by the cells' redox status. Interference with the activation or activity of NF-kappa B may be beneficial in suppressing toxic/septic shock, graft-vs-host reactions, acute inflammatory reactions, acute phase response, and radiation damage. The inhibition of NF-kappa B activation by antioxidants and specific protease inhibitors may provide a pharmacological basis for interfering with these acute processes.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

              NF-kappa B, which consists of two polypeptides, p50 (M(r) 50K) and p65/RelA (M(r) 65K), is thought to be a key regulator of genes involved in responses to infection, inflammation and stress. Indeed, although developmentally normal, mice deficient in p50 display functional defects in immune responses. Here we describe the generation of mice deficient in the RelA subunit of NF-kappa B. Disruption of the relA locus leads to embryonic lethality at 15-16 days of gestation, concomitant with a massive degeneration of the liver by programmed cell death or apoptosis. Embryonic fibroblasts from RelA-deficient mice are defective in the tumour necrosis factor (TNF)-mediated induction of messenger RNAs for I kappa B alpha and granulocyte/macrophage colony stimulating factor (GM-CSF), although basal levels of these transcripts are unaltered. These results indicate that RelA controls inducible, but not basal, transcription in NF-kappa B-regulated pathways.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                19 January 1998
                : 187
                : 2
                : 147-159
                Affiliations
                [* ]Laboratory of Immunoregulation, and []Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, and [§ ]Laboratory of Molecular Genetics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; []Division of Hematologic Products, and []Division of Cellular and Gene Therapies, Center for Biological Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892; [** ]Pathology/ Histotechnology Laboratory, Science Applications International Corporation and National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702
                Author notes

                Address correspondence to Dr. Ulrich Siebenlist, LIR, NIAID, NIH, 10 Center Dr., MSC 1876, Bldg. 10, Rm 11B-13, Bethesda, MD 20892-1876. Phone: 301-496-7662; Fax: 301-402-0070; E-mail: US3N@ 123456nih.gov . The present address of G. Franzoso is Gwen Knapp Center for Lupus and Immunology Research and the Ben May Institute for Cancer Research, The University of Chicago, Chicago, IL 60637.

                Article
                10.1084/jem.187.2.147
                2212099
                9432973
                4b668efb-6f66-484b-9cff-d62874129bfa
                Copyright @ 1998
                History
                : 25 August 1997
                : 29 October 1997
                Categories
                Article
                Articles

                Medicine
                Medicine

                Comments

                Comment on this article